← FDA Drug Approvals (Drugs@FDA)

BRIMONIDINE TARTRATE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: SANDOZ · Approved 2024-03-04

Drug application

FDA Application #

ANDA203172

Application type

Abbreviated New Drug Application (Generic)

Brand name

BRIMONIDINE TARTRATE

Generic name

BRIMONIDINE TARTRATE

Active ingredients

BRIMONIDINE TARTRATE

Dosage form

SOLUTION/DROPS

Route

OPHTHALMIC

Marketing status

Prescription

Sponsor

SANDOZ

Manufacturer

Sandoz Inc

First approval

2024-03-04

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown